UBS Group Cuts Axon Enterprise (NASDAQ:AXON) Price Target to $570.00

Axon Enterprise (NASDAQ:AXON) had its target price trimmed by UBS Group from $610.00 to $570.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a neutral rating on the biotechnology company’s stock.

A number of other brokerages also recently commented on AXON. Citigroup restated a “buy” rating on shares of Axon Enterprise in a research note on Wednesday. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a research note on Monday, December 29th. The Goldman Sachs Group cut their target price on shares of Axon Enterprise from $940.00 to $800.00 and set a “buy” rating for the company in a report on Wednesday, November 5th. William Blair restated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 3rd. Finally, Morgan Stanley cut their price objective on shares of Axon Enterprise from $713.00 to $675.00 and set an “overweight” rating for the company in a report on Wednesday. Sixteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $762.93.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $542.40 on Wednesday. The company has a 50 day simple moving average of $537.92 and a two-hundred day simple moving average of $625.54. The stock has a market cap of $43.61 billion, a price-to-earnings ratio of 356.84, a PEG ratio of 16.57 and a beta of 1.48. The company has a current ratio of 2.53, a quick ratio of 2.89 and a debt-to-equity ratio of 0.53. Axon Enterprise has a 12 month low of $396.41 and a 12 month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.55. The firm had revenue of $796.72 million during the quarter, compared to analysts’ expectations of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The firm’s revenue was up 38.5% compared to the same quarter last year. During the same quarter last year, the company posted $2.08 earnings per share. As a group, analysts predict that Axon Enterprise will post 5.8 earnings per share for the current year.

Insider Buying and Selling at Axon Enterprise

In related news, Director Jeri Williams sold 100 shares of Axon Enterprise stock in a transaction dated Thursday, December 4th. The stock was sold at an average price of $550.63, for a total value of $55,063.00. Following the sale, the director directly owned 1,316 shares in the company, valued at approximately $724,629.08. The trade was a 7.06% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Brittany Bagley sold 2,000 shares of the stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $580.00, for a total value of $1,160,000.00. Following the transaction, the chief financial officer directly owned 103,501 shares of the company’s stock, valued at $60,030,580. The trade was a 1.90% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 58,040 shares of company stock valued at $32,251,738. Corporate insiders own 4.40% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV acquired a new stake in Axon Enterprise during the 4th quarter worth $28,000. Stone House Investment Management LLC acquired a new position in Axon Enterprise during the third quarter worth about $29,000. New Millennium Group LLC acquired a new position in Axon Enterprise during the third quarter worth about $29,000. Sound Income Strategies LLC grew its stake in Axon Enterprise by 550.0% during the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after acquiring an additional 44 shares in the last quarter. Finally, Camelot Portfolios LLC acquired a new stake in Axon Enterprise in the 4th quarter valued at about $30,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise News Roundup

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q4 beat and bullish bookings — Axon reported a double beat (EPS and revenue), ~39% revenue growth and a material increase in future contracted bookings with raised multi‑year sales targets, which triggered the stock rally. Read More.
• Positive Sentiment: AI narrative driving subscription demand — Coverage highlights that Axon’s AI features (body‑camera analytics, Draft One report drafting, evidence management) are accelerating software adoption and upsells, supporting revenue visibility beyond hardware. Read More.
• Neutral Sentiment: Analysts recalibrating models — Several firms trimmed price targets after the print (Piper Sandler, others); many maintained buy/overweight stances, so these moves reflect model updates and volatility rather than a wholesale negative verdict. Read More.
• Neutral Sentiment: Short‑interest data flagged as anomalous — Recent short‑interest reports show zero/NaN figures (likely a reporting anomaly); nothing actionable from that data point for now.
• Negative Sentiment: Some analysts flag downside risk — Morgan Stanley and UBS issued more cautious outlooks/pessimistic scenarios that could cap upside if execution or margins slip. Read More. | Read More.
• Negative Sentiment: Profitability and margin recovery remain a watch item — Commentators note fast revenue growth but slower profit improvement and the need for FCF conversion; sustained margin progress is required to justify high multiples. Read More.
• Negative Sentiment: Insider sale disclosed — CEO Patrick Smith sold 10,000 shares (~$5.0M) on Feb. 25; small relative to his holdings but notable to traders monitoring insider activity. Read More.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.